(
EMAILWIRE.COM, July 28, 2017 )
According to the report
Nuclear Medicine Radiopharmaceuticals Market, published by Market Data Forecast, the Europe market is projected to reach USD 1780 million by 2021, at a CAGR of 11.4% from 2016 to 2021.
Using radioactive substances in diagnosis of the disease and its treatment is termed as nuclear medicine. In nuclear medicine, radiations emitting from the body are recorded instead of radiations from external sources.
Till now, SPECT Medicine Radiopharmaceuticals was the conventional modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change drastically because of shortage of Molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the secondary product of molybdenum. Hence, PET Medicine Radiopharmaceuticals products which includes hybrid PET-CT scanners holds a potential market size in coming years. The emerging market trend is fusion of nuclear Medicine Radiopharmaceuticals with different diagnostic Medicine Radiopharmaceuticals products such as PET/CT, SPECT/CT, and MRI/PET. This provides full range of Medicine Radiopharmaceuticals scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT Medicine Radiopharmaceuticals as it provides higher resolution images and the lack of availability of Technetium-99m is propelling industry to look for alternative diagnostic procedures.
Get a comprehensive overview of the Nuclear Medicine Radiopharmaceuticals Market:
http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/Nuclear Medicine Radiopharmaceuticals Market: Drivers & Restraints
Increase in use of PET and SPECT scans, increasing cases of cardiac ailment and cancer ailment and advancements in the field of immunotherapy based targeted cancer treatment have been the driving forces for the market. However factors like strict guidelines, short half-life of radiopharmaceuticals are proving to be hindrance.
Get accurate market forecast and analysis on the Nuclear Medicine Radiopharmaceuticals Market. Request a sample to stay up-to-date on the main trends affecting this market:
http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-sampleNuclear Medicine Radiopharmaceuticals Market: Segmentation
By Diagnostics
• PET
• SPECT
By Therapeutics
• Beta Emitters
• Alpha Emitters
• Brachytherapy
By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at
http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/customize-reportNuclear Medicine Radiopharmaceuticals Market: Overview
The demand SPECT and PET scans has increased as diseases like cancer and cardiac ailments have increased. Also integration of X ray tomography (CT) into SPECT is proving to be an excellent diagnostic imaging tool. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. There are many technical innovations in the market that are expected to contribute to the growth of the market during the forecast period. There has been an increase in the volume of the procedures that are being carried out; the CT market by itself is growing at 5-6% annually. The sales of MR contrast media and ultrasound contrast media have increased in the last few years.
Nuclear Medicine Radiopharmaceuticals Market: Region-wise Outlook
The European Market is segmented into various regions namely UK, Spain, Italy, Germany and France. Among nations Germany and UK will be the considerable markets because of developing social insurance spending plans and rising ubiquity of a few radiopharmaceuticals in various states.
Key Questions Answered
• What are the factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a regional scale in the Europe market?
• What is the competitive landscape and market share of major players in the nuclear Medicine Radiopharmaceuticals market in Europe?
• What are the key, high growth markets that nuclear Medicine Radiopharmaceuticals system manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the nuclear Medicine Radiopharmaceuticals systems currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of nuclear Medicine Radiopharmaceuticals systems?
• What are the challenges and barriers that have hindered widespread adoption of nuclear Medicine Radiopharmaceuticals in all medical areas?
• Who are the key market players along with the analysis of their current strategic interests and key financial information?
Nuclear Medicine Radiopharmaceuticals Market: Key Players
Some of the key players influencing the Europe nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
Reasons to buy Nuclear Medicine Radiopharmaceuticals Market Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit,
www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @
http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @
http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
